Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Subscribe

Sci. Signal., 10 March 2009
Vol. 2, Issue 61, p. pe12
[DOI: 10.1126/scisignal.261pe12]

PERSPECTIVES

When the Endogenous Hallucinogenic Trace Amine N,N-Dimethyltryptamine Meets the Sigma-1 Receptor

Tsung-Ping Su*1, Teruo Hayashi1, and D. Bruce Vaupel2

1 Cellular Pathobiology Section, Cellular Neurobiology Research Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, 333 Cassell Drive, Baltimore, MD 21224, USA.
2 Neuroimaging Research Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, 333 Cassell Drive, Baltimore, MD 21224, USA.

Abstract: N,N-dimethyltryptamine (DMT) is a hallucinogen found endogenously in human brain that is commonly recognized to target the 5-hydroxytryptamine 2A receptor or the trace amine–associated receptor to exert its psychedelic effect. DMT has been recently shown to bind sigma-1 receptors, which are ligand-regulated molecular chaperones whose function includes inhibiting various voltage-sensitive ion channels. Thus, it is possible that the psychedelic action of DMT might be mediated in part through sigma-1 receptors. Here, we present a hypothetical signaling scheme that might be triggered by the binding of DMT to sigma-1 receptors.

* Corresponding author. Cellular Pathobiology Section, IRP, NIDA, NIH Suite 3304, 333 Cassell Drive, Baltimore, MD 21224, USA. Telephone: 443-740-2804; fax: 443-740-2142; e-mail: TSU{at}intra.nida.nih.gov.

Citation: T.-P. Su, T. Hayashi, D. B. Vaupel, When the Endogenous Hallucinogenic Trace Amine N,N-Dimethyltryptamine Meets the Sigma-1 Receptor. Sci. Signal. 2, pe12 (2009).

Read the Full Text

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
In Vivo Long-Term Kinetics of Radiolabeled N,N-Dimethyltryptamine and Tryptamine.
A. A. Vitale, A. B. Pomilio, C. O. Canellas, M. G. Vitale, E. M. Putz, and J. Ciprian-Ollivier (2011)
J. Nucl. Med. 52, 970-977
   Abstract »    Full Text »    PDF »
Regulation of {sigma}-1 Receptors and Endoplasmic Reticulum Chaperones in the Brain of Methamphetamine Self-Administering Rats.
T. Hayashi, Z. Justinova, E. Hayashi, G. Cormaci, T. Mori, S.-Y. Tsai, C. Barnes, S. R. Goldberg, and T.-P. Su (2010)
J. Pharmacol. Exp. Ther. 332, 1054-1063
   Abstract »    Full Text »    PDF »

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882